The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
API
NEW
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
Dividends
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
API
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
FRA, 0GT: STOKE THERAPEUT.DL-001
27 Aug 2025
LAST:
16.40
CHANGE:
0.40
OPEN:
16.40
HIGH:
16.40
ASK:
0.00
VOLUME:
100
CHG(%):
2.50
PREV:
16.00
LOW:
16.40
BID:
0.00
CHART
Period:
End of Day
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
27 Aug 25
16.40
16.40
16.40
16.40
100
26 Aug 25
16.00
16.00
16.00
16.00
100
25 Aug 25
16.50
16.50
16.50
16.50
100
22 Aug 25
16.80
16.80
16.80
16.80
100
21 Aug 25
16.40
16.40
16.40
16.40
100
20 Aug 25
15.60
15.60
15.60
15.60
100
19 Aug 25
15.60
16.00
15.60
16.00
100
18 Aug 25
15.40
15.40
15.40
15.40
600
15 Aug 25
14.50
15.00
14.50
15.00
600
14 Aug 25
14.20
14.20
14.20
14.20
50
COMPANY PROFILE
Name:
STOKE THERAPEUT.DL-001
About:
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Address:
45 Wiggins Avenue, Bedford, MA, United States, 01730
Website:
https://www.stoketherapeutics.com
ISIN:
US86150R1077
LEI:
549300RD25SS2DIJHJ67
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Jan 01, 0001
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
Download
FUNDAMENTALS
P/E Ratio:
22.40
PtB:
3.19
PtS:
4.62
EBITDA:
42.27M
Shares:
54.8M
Market Cap:
898.68M
TECHNICAL INDICATORS
MA5:
16.42
MA10:
15.83
MA20:
13.66
MA50:
11.65
MA100:
9.91
MA200:
9.77
STO9:
77.78
STO14:
92.98
RSI14:
82.37
WPR14:
-7.02
MTM14:
5.10
ROC14:
0.45
ATR:
0.57
Week High:
16.80
Week Low:
15.60
Month High:
16.80
Month Low:
10.77
Year High:
16.80
Year Low:
5.18
Volatility:
96.27